Nutex Health Inc.

Description

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

About

CEO
Dr. Thomas T. Vo M.B.A., M.D.
Employees
800
Instrument type
Common Stock
Sector
Healthcare
Industry
Medical Care Facilities
MIC code
XNCM
Address
6030 South Rice Avenue, Houston, TX 77081, United States
Phone
713 660 0557
Website
Chart Image
× Enlarged Chart
Oscillators
No data available
Summary
No data available
Moving Averages
No data available

Earnings

Date Estimate EPS Actual EPS Difference % Surprise
Nov 6, 2025
Aug 6, 2025
May 7, 2025
Mar 27, 2025 -0.09
Nov 8, 2024 -0.24 -1.72 -1.48 616.67%

Earnings estimate

Next Quarter
(Mar 2025)
Next Year
(Dec 2025)
Number of analysts 1 1
Average estimate -0.15 2.13
Low estimate -0.15 2.13
High estimate -0.15 2.13
Last year EPS
[stock_revenue_estimate]

Growth estimates

Current qtr
Next qtr. (Mar 2025)
Current year
Next year (Dec 2025)
Next 5 years (per annum)
Past 5 years (per annum)

Analyst Ratings

Date Firm Action Rating Price Target
Nov 12, 2024
Maxim Group
Anthony Vendetti
Maintains Buy ▲ Raises $45 → $50
Nov 12, 2024
Benchmark
Bill Sutherland
Maintains Buy ▲ Raises $45 → $60
Sep 18, 2024
Maxim Group
Anthony Vendetti
Initiates Buy Announces $45
Aug 21, 2024
Benchmark
Bill Sutherland
Maintains Buy ▲ Raises $30 → $45
Jan 25, 2024
Benchmark
Bill Sutherland
Maintains Buy ▼ Lowers $1.5 → $1
Nov 14, 2023
Benchmark
Bill Sutherland
Maintains Buy ▼ Lowers $2.5 → $1.5
Aug 29, 2023
Benchmark
Bill Sutherland
Reiterates Buy Maintains $2.5
May 17, 2023
Benchmark
Bill Sutherland
Maintains Buy ▼ Lowers $3 → $2.5
Mar 9, 2023
Benchmark
Bill Sutherland
Reiterates Buy Maintains $3
Dec 23, 2022
Benchmark
Bill Sutherland
Initiates Buy Announces $3

Income statement

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total reported revenue 247.65M 219.29M 331.53M 274.03M 97.06M
Cost of revenue 212.87M 203.87M 152.25M 116.42M
Gross profit 34.77M 15.42M 179.28M 157.61M
Operating expense
Research & development
Selling general and admin 36.07M 20.00M 5.46M 4.43M 59.87M
Other operating expenses 217,266
Operating income -1.51M -4.58M 173.82M 153.17M 34.71M
Non operating interest income
Income
Expense 16.32M 12.49M 6.20M 6.43M 3.53M
Other income expense -30.66M -402.58M 1.87M -1.00M 909,162
Pretax income -48.49M -419.65M 169.49M 145.74M 32.09M
Tax provision -5.07M 13.09M 965,731 181,341
Net income -43.42M -432.74M 168.53M 145.56M 32.09M
Basic EPS -10.50 -100.50 30.90 24.69 4.88
Diluted EPS -10.50 -100.50 30.90 24.69 4.88
Basic average shares 4.36M 4.23M 4.29M 4.29M 4.29M
Diluted average shares 4.36M 4.23M 4.29M 4.29M 4.29M
EBITDA 15.68M 7.99M 186.90M 158.07M 38.10M
Net income from continuing op. -43.42M -432.74M 168.53M 145.56M 32.09M
Minority interests -2.36M 7.96M -35.93M -39.59M -11.17M
Preferred stock dividends

Balance sheet

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 398.25M 431.75M 394.65M 308.55M 179.22M
Current assets
Cash
Cash equivalents
Cash and cash equivalents 22.00M 34.26M 36.12M 25.51M 8.00M
Other short term investments
Accounts receivable 62.78M 58.32M 114.76M 108.14M 36.14M
Other receivables
Inventory 3.39M 3.53M 2.81M 1.73M 899,915
Prepaid assets 130,570 700,074
Restricted cash
Assets held for sale
Hedging assets
Other current assets 2.68M 1.87M 323,283
Non current assets
Properties 223.09M 242.97M 113.29M 48.63M 66.59M
Land and improvements 4.40M 3.72M 18.20M 17.04M 10.25M
Machinery furniture equipment 9.90M 4.71M 4.32M 22.54M 15.83M
Construction in progress 12.85M 19.39M 4.30M 4.04M
Leases 27.61M 28.86M 27.04M 25.01M 15.89M
Accumulated depreciation -18.34M -13.01M -11.59M -6.56M -3.14M
Goodwill 54.65M 55.21M 2.96M 2.28M 2.28M
Investment properties
Financial assets
Intangible assets 20.51M 21.19M 682,649
Investments and advances
Other non current assets 431,135 423,426 456,085 1.10M 1.06M
Total liabilities 319.14M 311.42M 203.07M 161.19M 128.39M
Current liabilities
Accounts payable 25.28M 27.53M 17.65M 8.63M 5.29M
Accrued expenses 12.96M 6.24M 6.86M 2.44M 3.16M
Short term debt 20.08M 21.09M 13.17M 20.39M 63.68M
Deferred revenue
Tax payable 1.03M
Pensions
Other current liabilities
Non current liabilities
Long term debt 255.68M 246.11M 165.38M 129.73M 56.26M
Provision for risks and charges
Deferred liabilities 5.15M 10.45M
Derivative product liabilities
Other non current liabilities
Shareholders equity
Common stock 676,680 650,224 592,792
Retained earnings -409.07M -363.29M 102.32M
Other shareholders equity
Total shareholders equity 79.11M 120.33M 191.58M 147.37M 50.84M
Additional paid in capital 469.85M 458.50M 11.74M
Treasury stock
Minority interest 17.65M 24.46M 76.93M 61.56M 22.53M

Cash flow statement

20232022202120202019
Operating Activities
Net Income-43.42M-432.74M168.53M145.56M32.09M
Depreciation17.59M13.13M7.66M5.90M2.48M
Deferred Taxes-5.71M5.00M
Stock-Based Compensation2.84M189,581
Other Non-Cash Items1.40M2.02M38,3571.24M-596,941
Accounts Receivable-4.58M58.08M-6.62M-71.23M-24.74M
Accounts Payable-2.25M9.69M6.27M6.23M1.63M
Other Assets & Liabilities142,701-719,107-1.09M-861,983-609,581
Operating Cash Flow-33.99M-345.36M174.78M86.83M10.25M
Investing Activities
Capital Expenditures-9.50M-14.63M-36.93M-61.19M-32.28M
Net Intangibles
Net Acquisitions-1.74M10.30M-48,8531.04M
Purchase of Investments
Sale of Investments
Investing Cash Flow-11.24M-4.34M-36.98M-61.19M-31.23M
Financing Activities
Long-Term Debt Issuance21.86M815,88119.61M57.17M39.20M
Long-Term Debt Payments-21.56M-9.03M-22.84M-16.91M-5.93M
Other Financing Charges298,0324.51M21.71M9.81M5.05M
Financing Cash Flow-3.86M-52.38M-126.72M-10.64M21.14M
Other Cash Details
End Cash Position22.00M34.26M36.12M25.51M8.00M
Income Tax Paid849,3588.23M335,340181,341
Interest Paid1.64M4.62M4.10M3.25M427,405
Free Cash Flow-8.24M35.97M136.51M25.48M-20.15M
Error: Invalid format in Holders JSON file.
Nutex Health Issues No Surprises Act (NSA) Arbitration Update Article
Nutex Health Issues No Surprises Act (NSA) Arbitration Update
HOUSTON , Feb. 5, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today provided an update regarding its strategic participation in arbitration known as the Independent Dispute Resolution ("IDR") process under the No Surprises Act ("NSA"). As previously disclosed in our September 30, 2024 Form 10-Q, on July 1, 2024 the Company contracted with a third-party vendor to assist in the recovery of certain out of network claims under the arbitration process.
PRNewsWire Neutral
Feb 5, 2025
Nutex Health Hospitals Earn Multiple Community Honors and Awards in Q4 Article
Nutex Health Hospitals Earn Multiple Community Honors and Awards in Q4
HOUSTON , Jan. 21, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that its hospitals have won multiple community-driven awards and accolades in the fourth quarter of 2024. These recognitions highlight the staff's ongoing commitment to excellence in healthcare delivery.
PRNewsWire Neutral
Jan 21, 2025
NUTEX HEALTH OPENS STARKEY RANCH ER & HOSPITAL, ITS FIRST HOSPITAL IN FLORIDA Article
NUTEX HEALTH OPENS STARKEY RANCH ER & HOSPITAL, ITS FIRST HOSPITAL IN FLORIDA
NUTEX HEALTH CONTINUES TO BROADEN ITS NATIONAL PRESENCE WITH ITS FOURTH HOSPITAL OPENING IN 2024 HOUSTON , Jan. 13, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, announced the opening of Starkey Ranch ER & Hospital on December 30, 2024, located at 2253 Heart Pine Ave. in Odessa, Florida.
PRNewsWire Neutral
Jan 13, 2025
Scroll to Top

Markets

Crypto

how to invest

Who we are